FAT1 is a target antigen in a subset of de novo allograft membranous nephropathy associated with antibody mediated rejection

Sethi, S., Madden, B., Casal Moura, M., Nasr, S. H., Alexander, M. P., Debiec, H., Torrel, N., Gross, L., Negron, V., Specks, U., Fervenza, F. C., Haas, M., Ronco, P., & Batal, I. (2024). FAT1 is a target antigen in a subset of de novo allograft membranous nephropathy associated with antibody mediated rejection. Kidney international, S0085-2538(24)00569-6. Advance online publication. https://doi.org/10.1016/j.kint.2024.08.009

Authors:
Sanjeev Sethi
Benjamin Madden
Marta Casal Moura
Samih H Nasr
Mariam P Alexander
Hanna Debiec
Nate Torrel
LouAnn Gross
Vivian Negron
Ulrich Specks
Fernando C Fervenza
Mark Haas
Pierre Ronco
Ibrahim Batal
Affiliated Authors:
Ibrahim Batal
Columbia Affiliation:
Author Keywords:
antibody-mediated rejection
de novo membranous nephropathy
fat1
kidney transplant
elink
Publication Type:
Article
Unique ID:
10.1016/j.kint.2024.08.009
PMID:
39181399
DOI:
10.1016/j.kint.2024.08.009
Journal:
Kidney International
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record
View Scopus Record

Record Created: